Terms: = Liver cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148
14 results:
1. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
[TBL] [Abstract] [Full Text] [Related]
2. Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development.
Seo EB; Jang HJ; Kwon SH; Kwon YJ; Kim SK; Lee SH; Jeong AJ; Shin HM; Kim YN; Ma S; Kim H; Lee YH; Suh PG; Ye SK
Hepatol Commun; 2022 Nov; 6(11):3234-3246. PubMed ID: 36153805
[TBL] [Abstract] [Full Text] [Related]
3. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
Yu H; Bai X; Zheng W
Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
[TBL] [Abstract] [Full Text] [Related]
4. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012-2017.
Abou Saleh M; Mansoor E; Anindo M; Isenberg G
Dig Dis Sci; 2019 May; 64(5):1328-1334. PubMed ID: 30519851
[TBL] [Abstract] [Full Text] [Related]
6. Phosphoinositide-specific phospholipase Cγ1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells.
Dai L; Chen X; Lu X; Wang F; Zhan Y; Song G; Hu T; Xia C; Zhang B
Sci Rep; 2017 Oct; 7(1):13912. PubMed ID: 29066806
[TBL] [Abstract] [Full Text] [Related]
7. Phospholipase C gamma 1 (plcg1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract] [Full Text] [Related]
9. Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme.
Waugh MG
Mol Neurobiol; 2016 Jan; 53(1):621-630. PubMed ID: 25502460
[TBL] [Abstract] [Full Text] [Related]
10. [Nanogold inhibits angiogenesis and growth of liver cancer: experiment with mice].
Pan YL; Qiu SY; Qin L; Cai JY; Sun JS
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):800-4. PubMed ID: 19595116
[TBL] [Abstract] [Full Text] [Related]
11. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase.
Bae YS; Sung JY; Kim OS; Kim YJ; Hur KC; Kazlauskas A; Rhee SG
J Biol Chem; 2000 Apr; 275(14):10527-31. PubMed ID: 10744745
[TBL] [Abstract] [Full Text] [Related]
12. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells.
Wiedmann KH; Trejdosiewicz LK; Southgate J; Thomas HC
Hepatology; 1987; 7(3):543-50. PubMed ID: 2437001
[TBL] [Abstract] [Full Text] [Related]
13. In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5.
Dunk AA; Brown D; Weidmann K; Thomas HC
J Hepatol; 1987 Feb; 4(1):52-61. PubMed ID: 3033060
[TBL] [Abstract] [Full Text] [Related]
14. Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies.
Shouval D; Eilat D; Carlson RI; Adler R; Livni N; Wands JR
Hepatology; 1985; 5(3):347-56. PubMed ID: 2987098
[TBL] [Abstract] [Full Text] [Related]
